US 2018/0002310 A1 · CRYSTALLINE FORMS OF EFINACONAZOLE

Abstract

The present invention provides crystalline forms of efinaconazole, including crystalline efinaconazole forms designated herein as Form A, Form B and Form C, crystalline efinaconazole p-toluenesulfonate salt designated herein as Form I, and processes for their preparation.

Claims11

Dependent claims

Crystalline efinaconazole Form A.

Dependencies are inferred from the claim text.

Facts

Application

15/544,173Filed 2 Dec 2015

Priority

20 Jan 2015

Published

4 Jan 2018

Term ends

Not estimatedThe source records don’t support an estimate.

Classification11 codes

C07D 401/06
Containing two hetero rings: linked by a carbon chain containing only aliphatic carbon atoms
A61K 9/0014
Galenical forms characterised by the site of application: skin, i.e. galenical aspects of topical compositions
A61K 9/08
Medicinal preparations characterised by special physical form: solutions
A61K 47/10
Containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides: alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene…

Abstract

Claims11

Dependent claims

Crystalline efinaconazole Form A.

Dependencies are inferred from the claim text.

Crystalline forms of efinaconazole

Life of this patent

Abstract

Claims11

Crystalline forms of efinaconazole

Life of this patent

Abstract

Claims11